Loading clinical trials...
Loading clinical trials...
A Study to Evaluate Pharmacokinetics, Safety, and Tolerability of ABBV-903 in Healthy Japanese and Han Chinese Subjects
Conditions
Interventions
ABBV-903
Placebo for ABBV-903
Locations
1
United States
Anaheim Clinical Trials LLC /ID# 257033
Anaheim, California, United States
Start Date
August 23, 2023
Primary Completion Date
October 30, 2023
Completion Date
October 30, 2023
Last Updated
November 13, 2023
NCT07310264
NCT06342713
NCT07472361
NCT06649110
NCT06823947
NCT07240675
Lead Sponsor
AbbVie
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions